Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

Drug therapy often fails to control hypertension. Azilsartan medoxomil (AZL-M) is a newly developed angiotensin II receptor blocker with high efficacy and good tolerability. This double-blind, controlled, randomised trial compared its antihypertensive efficacy and safety vs the angiotensin-convertin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bönner, G, Bakris, G L, Sica, D, Weber, M A, White, W B, Perez, A, Cao, C, Handley, A, Kupfer, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715765/
https://www.ncbi.nlm.nih.gov/pubmed/23514842
http://dx.doi.org/10.1038/jhh.2013.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715765/
https://www.ncbi.nlm.nih.gov/pubmed/23514842
http://dx.doi.org/10.1038/jhh.2013.6

Ejemplares similares